Medico Remedies Ltd.

86.75 +6.72 ▲8.4%

08 December 2023, 04:01:00 PM
Volume: 55,950

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.medicoremediesindia.com / www.medicoremediesindia.net / www.tabletandcapsules.com
Market Cap 719.89 Cr.
Enterprise Value(EV) 724.20 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.94 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 92.73 Trailing Twelve Months Ending 2023-09
Industry PE 38.52 Trailing Twelve Months Ending 2023-09
Book Value / Share 5.74 Trailing Twelve Months Ending 2023-09
Price to Book Value 15.12 Calculated using Price: 86.75
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 8.30 Cr. 82,984,000 Shares
FaceValue 2
About Medico Remedies Ltd.
The company is engaged in manufacturing and selling of pharmaceutical formulation products in India. The company offers formulation pharmacy products including anti-infective, beta lactum, cephalosporin, antimalarial, antiretroviral, and anti-ulcer drugs, as well as antacids; vitamins, haematinics and other supplements and nonsteroidal anti-inflammatory drugs, antihistaminics, anti-diabetics, cardio vascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and creams and gels.

Medico Remedies Ltd. Delivery

Delivered Qty
Traded Qty

Medico Remedies Ltd. Performance

1 Day
+8.40%
1 Week
+11.43%
1 Month
+15.94%
3 Month
+18.95%
6 Month
+4.15%
1 Year
+39.76%
2 Year
+205.67%
5 Year
+1785.87%
10 Year

Medico Remedies Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 7.14 7.97 10.47 5.67 5.72 5.61 8.31 13.94 18.01
Return on Capital Employed (%) 10.01 10.86 9.39 9.05 7.79 7.66 10.13 15.09 21.88
Return on Assets (%) 2.36 2.78 3.47 2.26 2.31 2.15 3.43 6.24 8.63

Medico Remedies Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 14 15 16 27 28 30 32 37 44 48
Non Curr. Liab. 1 4 11 3 3 5 5 3 2 2
Curr. Liab. 22 26 21 30 45 40 38 40 43 53
Minority Int.
Equity & Liab. 36 46 48 59 76 75 76 79 89 102
Non Curr. Assets 10 9 10 14 17 19 17 20 23 22
Curr. Assets 26 37 38 46 59 57 58 59 66 81
Misc. Exp. not W/O
Total Assets 36 46 48 59 76 75 76 79 89 102

Medico Remedies Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 51 67 54 61 98 89 122 121 140 141
Other Income 0 0 0 1 2 2 1 2 4 2
Total Income 51 67 55 62 100 91 123 123 145 143
Total Expenditure -48 -63 -50 -58 -95 -86 -117 -114 -131 -129
PBIDT 3 4 4 4 5 5 6 9 14 14
Interest -1 -1 -1 -2 -1 -1 -1 -1 -1 -1
Depreciation -1 -1 -1 -1 -2 -2 -2 -2 -3 -3
Taxation 0 -1 0 -1 -1 -1 -1 -2 -3 -3
Exceptional Items 0
PAT 1 1 2 1 2 2 3 5 7 8
Adjusted EPS 0 0 0 0 0 0 0 1 1 2

Medico Remedies Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 3 0 -4 -3 5 5 1 -11 6 8
Cash Fr. Inv. -4 -2 0 -3 -5 -4 -3 -17 -2 -7
Cash Fr. Finan. 2 3 2 6 -1 -1 3 18 -6 -2
Net Change 1 0 -1 0 -1 0 0 -10 -2 0
Cash & Cash Eqvt 1 2 1 0 0 0 1 -10 1 1

Medico Remedies Ltd. Shareholding Pattern

9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 73.34 73.34 73.34 73.34 73.34 73.34 73.34 73.34 73.34
Public 26.66 26.66 26.66 26.66 26.66 26.66 26.66 26.66 26.66
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Medico Remedies Ltd. Announcements

Sat, 11 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
In Compliance with Regulation 47 of SEBI (LODR) Regulations 2015 please find attached newspaper advertisements for publication of announcement of unaudited financial results for the quarter and half year ended 30th September 2023.
Thu, 09 Nov 2023
Board Meeting Outcome for Outcome Of Board Meeting Held Today
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors at their Meeting held today i.e. 9" November 2023 has inter alia considered and approved the Unaudited Financial Results for the quarter andhalf year ended 30" September 2023 alongwith Auditors Limited Review Report thereon.We wish to inform you that the Board Meeting commenced today at 3.00 P.M and concluded at 5.10P.M
Thu, 09 Nov 2023
Outcome Of Board Meeting Held Today
Please find attached Unaudited Financial Results for the quarter and half year ended 30th September 2023 approved at Board meeting held today.

Medico Remedies Ltd. Technical Scans

Fri, 08 Dec 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Month High Close Crossing Last Month High
Closing Above Previous High Closing Above Previous High

Medico Remedies Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 296,437.84 1,235.50 -0.3%
Cipla Ltd. 98,444.27 1,218.85 -0.3%
Divi's Laboratories Ltd. 97,728.28 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. 96,135.30 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. 79,790.42 5,542.00 +1.5%
Mankind Pharma Ltd. 78,250.95 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. 69,508.23 2,056.00 -2.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.68 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-09 28.51 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 73.38 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.88 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.40 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 61.04 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.11 2,056.00 -2.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.96 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-09 3.97 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 7.71 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.77 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.27 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 9.28 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.36 2,056.00 -2.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,056.00 -2.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.00 -2.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.00 -2.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,056.00 -2.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,056.00 -2.2%

Medico Remedies Ltd. FAQ's

What is Medico Remedies share price?

Can I buy Medico Remedies shares now?

What is the Market Cap of Medico Remedies?

What are the key metrics to analyse Medico Remedies?

What is the 52 Week High and Low of Medico Remedies?

What is the trend of Medico Remedies share price?